{"groups":[{"description":"cisplatin 75 mg/m2, pemetrexed 500 mg/m2 and bevacizumab 15 mg/kg IV every 3 weeks","id":"FG000","title":"Cisplatin, Pemetrexed and Bevacizumab"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"53"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"53"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"Patients recruited from investigators clinics"}